Condition

Lung Disease

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 23 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials23
Recruiting3
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

23 shown
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCNCT07489066 · 2026-06-30
RECRUITING
Cognitive Screening in Lung Cancer PatientsNCT06727370 · 2024-01-10
RECRUITING
Study of the Disease Process of LymphangioleiomyomatosisNCT00001465 · 1995-12-18
RECRUITING
Respiratory Virus Infections in Acutely Hospitalized Adult Patients With Pulmonary and Extrapulmonary ComplicationsNCT03816059 · 2019-02-12
UNKNOWN
A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLCNCT03085069 · 2017-05-03
UNKNOWN
Swimming Pool Environment Impact on the Human Respiratory HealthNCT03017976 · 2017-01-01
UNKNOWN
The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion DiagnosisNCT02965300 · 2016-10-01
UNKNOWN
Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung DisordersNCT02946658 · 2016-10-01
SUSPENDED
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung DiseaseNCT02055222 · 2014-10-14
COMPLETED
Abdominal Circumference and Cardiorespiratory Repercussions in Patients Submitted to Physical TherapyNCT02217423 · 2014-09-01
COMPLETED
Etiologies, Investigations and Outcomes of Patients Presenting With HemoptysisNCT02913365 · 2012-10-01
UNKNOWN
Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.NCT02168036 · 2011-08-16
TERMINATED
To Evaluate the Effect of AZD3199 on the Electrical Activity in the HeartNCT01222442 · 2010-11-01
COMPLETED
Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)NCT01153321 · 2010-10-01
COMPLETED
AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)NCT01215279 · 2010-10-01
COMPLETED
Minimally Invasive Endoscopy in Diffuse Lung DiseaseNCT00934778 · 2009-06-01
COMPLETED
DREAM: Does Inhaled Fluticasone REsult in Obstructive Sleep Apnea Manifestations?NCT01184118 · 2009-03-01
COMPLETED
Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung DiseaseNCT00504738 · 2006-04-01
COMPLETED
Non-invasive Ways to Evaluate Lung Disease After Treatment With XolairNCT00139152 · 2005-09-01
COMPLETED
Evaluation of the Lungs of Individuals With Lung DiseaseNCT00224198 · 2004-01-01
COMPLETED
Natrecor in Pulmonary HypertensionNCT00075179 · 2003-12-31
TERMINATED
Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric OxideNCT00041574 · 2002-04-01
TERMINATED
Biomarkers of Benzene Exposure in Inner City ResidentsNCT00014963
COMPLETED

Common interventions

Trial status mix

COMPLETED11
UNKNOWN5
RECRUITING3
TERMINATED3
SUSPENDED1

Phase mix

PHASE26
NA3
PHASE12
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.